
化工股長興材料公告8月稅前盈餘2.69億元、年成長28.05%,每股稅前盈餘0.23元。累計1-8月稅前盈餘22.95億元、年增37.31%,主因產品組合優化及半導體先進封裝材料出貨升溫。
AI-generated summary
長興材料公告自結8月及1-8月財務表現,顯示本業獲利成長。
化工股長興材料(1717)今日公告自結8月稅前盈餘2.69億元、年成長28.05%,每股稅前盈餘0.23元;累計1-8月稅前盈餘22.95億元、年增37.31%,每股稅前盈餘達1.96元。
長興8月營收40.70億元、年成長20.95%,其中,合成樹脂、特用材料出貨量略較上月回落,精密設備、半導體先進封裝材料則明顯升溫,長興指出,雖然原料成本增加,但產品組合優化,8月毛利率較上月提升,營業利益2.56億元、稅前盈餘2.69億元,分別較去年同期成長72.85%、28.05%。
長興也說,今年以來產品組合持續優化,反映在本業獲利成長,隨著精密設備密集驗收、半導體先進封裝材料出貨量提升,下半年旺季效益可期。
AI outlook — possibilities, not facts
下半年旺季效益可期
Likely · Within months

The Central Bank announced the financial situation in August. As the AI industry boom continues to heat up corporate capital needs, the annual growth rate of all monetary institutions' lending and investment rose to 9.43%, of which the annual growth rate of bank lending reached 10.49%, a new high since January 2005.

A publication under China’s industry ministry rejected 'de-CATLisation' market chatter as automakers diversify battery suppliers and CATL shares fall.

Industrial computer manufacturer IEI said at the press conference that its Netcom business will be its main growth engine this year, and its order visibility will extend to 2027. Israeli information security customers will contribute approximately 1.5 billion yuan. High-end video systems have been mass-produced since the second quarter, with momentum extending to 2028, and the company is actively exploring physical AI robot business opportunities.

Tesla CEO Elon Musk praised Chinese President Xi Jinping as a great and capable leader in an interview with state broadcaster CCTV, citing the nation's immense prosperity under his tenure.
Zhou Ningren, a global senior managing partner at McKinsey, pointed out that the future competition in China’s banking industry will shift from scale competition to value creation competition. As business models differentiate and artificial intelligence accelerates its popularity, banks need to effectively combine technology with wealth management and promote AI from scattered pilots to large-scale value release.
Bank of China launched the "Drug Traceability Code" factoring business and the "1+4" service matrix, and supported the innovative development and internationalization process of biopharmaceutical companies throughout the chain through innovative products such as "Pipeline R&D Loan" and "BD Loan".